{
  "meta": {
    "title": "Cataract_Surgery_Complications",
    "url": "https://brainandscalpel.vercel.app/cataract-surgery-complications-f8e9fea9.html",
    "scrapedAt": "2025-11-29T18:31:17.748Z"
  },
  "questions": [
    {
      "id": 18289,
      "choices": [
        {
          "id": 73114,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Adrenaline </span></span></span></p>"
        },
        {
          "id": 73115,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Atropine </span></span></span></p>"
        },
        {
          "id": 73116,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Heparin </span></span></span></p>"
        },
        {
          "id": 73117,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Dexamethasone </span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\">​​​​​<span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">In a child undergoing cataract surgery, which of the following is added to the irrigating solution to prevent postoperative inflammatory membrane formation? </span></span></span></p>",
      "unique_key": "Q9924123",
      "question_audio": null,
      "question_video": null,
      "map_id": 31210,
      "difficulty_level": "difficult",
      "subjects_id": [
        8
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. C) Heparin &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C: </span></strong><span style=\"font-size:12.0pt\">The role of infusion fluid during cataract surgery:</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ol>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">To aid in the </span><strong><span style=\"font-size:12.0pt\">smooth removal of the lens</span></strong><span style=\"font-size:12.0pt\"> and </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Restore the aqueous humor</span></strong><span style=\"font-size:12.0pt\"> at the end of the procedure.</span></span></span></li>\r\n</ol>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Additives to Infusion Fluid: </span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ol>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Preservative-Free Antibiotics &ndash; <strong>Prophylaxis</strong> </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Adrenaline 0.3ml of 1:1000 in 500ml &ndash; to maintain <strong>Mydriasis</strong>.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Preservative free <strong>Low Molecular Weight Heparin</strong> 10 IU/ml &ndash; prevent <strong>postoperative severe fibrinous inflammatory membrane</strong> formation in children. </span></span></span></li>\r\n</ol>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Adrenaline (Epinephrine)&nbsp;</span></strong><span style=\"font-size:12.0pt\">is often <strong>added</strong> to <strong>local anesthetic solutions</strong> to <strong>constrict blood vessels,</strong> thereby <strong>reducing bleeding</strong> and <strong>prolonging</strong> the <strong>duration</strong> of <strong>anesthesia</strong>. While it may help in <strong>maintaining pupil dilation</strong> during <strong>surgery</strong>, it is not primarily used for controlling postoperative inflammation.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Atropine&nbsp;</span></strong><span style=\"font-size:12.0pt\">is a <strong>muscarinic antagonist</strong> that causes <strong>dilation</strong> of the <strong>pupil</strong> and <strong>paralysis</strong> of <strong>accommodation</strong>. It is not typically used in the irrigating solution during cataract surgery, and its primary role is not in controlling postoperative inflammation.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Dexamethasone&nbsp;</span></strong><span style=\"font-size:12.0pt\">is a <strong>corticosteroid</strong> used for its <strong>anti-inflammatory</strong> and <strong>immunosuppressive effects</strong>. While it is commonly used in <strong>ophthalmology</strong> for <strong>controlling inflammation</strong>, it is <strong>typically administered</strong> as an <strong>eye drop</strong> or <strong>injection</strong>, not in the irrigating solution during surgery.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Heparin&nbsp;</span></strong><span style=\"font-size:12.0pt\">is added to the <strong>irrigating solution</strong> during <strong>pediatric cataract</strong> <strong>surgery</strong> to <strong>prevent</strong> the <strong>formation</strong> of <strong>postoperative inflammatory membranes</strong>.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref:&nbsp;</span></span></u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">PARSONS DISEASES OF THE EYE PAGE 158</span></span></strong></p>",
      "correct_choice_id": 73116,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 18287,
      "choices": [
        {
          "id": 73106,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">1% Atropine </span></span></span></p>"
        },
        {
          "id": 73107,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">0.03% Flurbiprofen </span></span></span></p>"
        },
        {
          "id": 73108,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">10% Phenylephrine </span></span></span></p>"
        },
        {
          "id": 73109,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">0.5% Proparacaine </span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">For a patient scheduled for cataract surgery, a pharmacological agent was administered before the procedure to prevent intraoperative miosis. This drug, commonly used in such cases, helps maintain pupil dilation during surgery, facilitating optimal visualization of the surgical field. Identify the drug that was administered.</span></span></span></p>",
      "unique_key": "Q4110615",
      "question_audio": null,
      "question_video": null,
      "map_id": 31209,
      "difficulty_level": "difficult",
      "subjects_id": [
        8
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. B) 0.03% Flurbiprofen </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B: Flurbiprofen&nbsp;</span></strong><span style=\"font-size:12.0pt\">is an <strong>NSAID</strong>.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">During surgery, there is a release of <strong>prostaglandins</strong> which causes <strong>miosis</strong>. This is prevented by <strong>NSAIDs</strong> through <strong>cyclooxygenase</strong> <strong>pathway inhibition</strong>.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Other alternatives:</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Indomethacin 0.5%- 1%</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Ketorolac 0.4%</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. 1% Atropine&nbsp;</span></strong><span style=\"font-size:12.0pt\">is a <strong>muscarinic antagonist</strong> that causes <strong>pupil dilation</strong> (<strong>mydriasis</strong>) and <strong>paralysis</strong> of <strong>accommodation</strong> (<strong>cycloplegia</strong>).</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. 10% Phenylephrine&nbsp;</span></strong><span style=\"font-size:12.0pt\">is an <strong>alpha-1 adrenergic receptor agonist</strong> that <strong>induces mydriasis</strong> <strong>without cycloplegia</strong>. It is often used in <strong>cataract surgery</strong> to <strong>maintain pupil dilation</strong>. Its <strong>rapid onset</strong> and <strong>effectiveness</strong> in <strong>dilating</strong> the <strong>pupil</strong> make it a <strong>common choice</strong> for this purpose.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. 0.5% Proparacaine&nbsp;</span></strong><span style=\"font-size:12.0pt\">is a <strong>topical anesthetic</strong> used in <strong>ophthalmology</strong> to <strong>anesthetise</strong> the <strong>cornea</strong>.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The <strong>drug administered</strong> to <strong>prevent intraoperative miosis</strong> during <strong>cataract surgery</strong> is <strong>0.03% Flurbiprofen, an NSAID</strong>, as it specifically <strong>targets</strong> the <strong>prevention</strong> of <strong>miosis</strong> during <strong>surgical procedures</strong>. While <strong>phenylephrine</strong> is also a <strong>mydriatic agent</strong>, its primary role is not the prevention of miosis but rather the <strong>induction</strong> of <strong>mydriasis</strong>. <strong>Flurbiprofen&#39;s role</strong> in <strong>inhibiting prostaglandin synthesis</strong> directly <strong>counteracts</strong> the factors that <strong>cause miosis</strong> during <strong>surgery.</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref:&nbsp;</span></span></u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Parsons Diseases of Eye 22<sup>nd</sup> Edition Page 155</span></span></strong></p>",
      "correct_choice_id": 73107,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 18291,
      "choices": [
        {
          "id": 73122,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Sodium Hyaluronate </span></span></span></p>"
        },
        {
          "id": 73123,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Hydroxypropyl Methylcellulose </span></span></span></p>"
        },
        {
          "id": 73124,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Sodium Hyaluronate + Chondroitin Sulphate </span></span></span></p>"
        },
        {
          "id": 73125,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Keratan Sulphate</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A patient posted for cataract surgery has a corneal endothelial cell count of 1250 cells/mm<sup>2</sup>. Which of the following ophthalmic visco-surgical devices would the surgeon prefer? </span></span></span></p>",
      "unique_key": "Q1287015",
      "question_audio": null,
      "question_video": null,
      "map_id": 31211,
      "difficulty_level": "intermediate",
      "subjects_id": [
        8
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. C) Sodium Hyaluronate + Chondroitin Sulphate </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C: </span></strong><span style=\"font-size:12.0pt\">The average corneal endothelial cell count is <strong>2800 cells/mm<sup>2</sup></strong>. Since this patient has a <strong>lower cell count</strong>, the corneal endothelium protection is vital. Hence, we&rsquo;ll choose a <strong>Dispersive OVD</strong>.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/27/screenshot-2024-01-27-113958.jpg\" style=\"height:211px; width:1000px\" /></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A.&nbsp;</span></strong><span style=\"font-size:12.0pt\">Sodium Hyaluronate is a commonly used <strong>cohesive OVD</strong> in <strong>cataract surgery</strong>. It is <strong>effective</strong> in <strong>maintaining space</strong> and <strong>protecting</strong> the <strong>cornea</strong>.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B.&nbsp;</span></strong><span style=\"font-size:12.0pt\">Hydroxypropyl Methylcellulose (HPMC) is a <strong>less cohesive</strong>, <strong>more dispersive</strong> OVD compared to <strong>sodium hyaluronate</strong>.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D.&nbsp;</span></strong><span style=\"font-size:12.0pt\">Keratan Sulphate is not commonly used as an OVD in cataract surgery. It&#39;s more known for its <strong>presence</strong> in the <strong>corneal stroma</strong>, but it doesn&#39;t have the viscoelastic properties required for an OVD.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Given the patient&#39;s <strong>low endothelial cell count</strong>, the surgeon would prefer <strong>Sodium Hyaluronate + Chondroitin Sulphate</strong>. This combination provides <strong>both</strong> the <strong>space-maintaining benefits</strong> of <strong>sodium hyaluronate (cohesive)</strong> and the <strong>endothelial protective properties</strong> of <strong>chondroitin sulphate (dispersive)</strong>, making it ideal for cases where the <strong>corneal endothelium</strong> is <strong>compromised</strong>.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Endothelial cell protection is mainly a <strong>function</strong> of <strong>dispersive OVD</strong>.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Ref:&nbsp;</span></u></strong><strong><span style=\"font-size:12.0pt\">PARSONS DISEASES OF THE EYE PAGE 159</span></strong></span></span></p>",
      "correct_choice_id": 73124,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 18542,
      "choices": [
        {
          "id": 74126,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">TORIC ICL Implantation.</span></span></span></p>"
        },
        {
          "id": 74127,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Phacoemulsification with Toric IOLS Implantation</span></span></span></p>"
        },
        {
          "id": 74128,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Phacoemusification with Multifocal IOL Implantation</span></span></span></p>"
        },
        {
          "id": 74129,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">MSICS </span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A patient evaluated for cataract surgery also had residual cylinder power correction needed. What would be the procedure of choice to address both the situations?</span></span></p>",
      "unique_key": "Q5500206",
      "question_audio": null,
      "question_video": null,
      "map_id": 31207,
      "difficulty_level": "intermediate",
      "subjects_id": [
        8
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. B) Phacomeulsification with Toric IOLS implantation</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Toric IOLs&nbsp;</span></strong><span style=\"font-size:12.0pt\">refers to <strong>astigmatism</strong> correcting <strong>intraocular lenses</strong> used at the time of <strong>cataract surgery</strong> to <strong>decrease astigmatism</strong>.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The patient should have visually <strong>significant cataract</strong> and <strong>astigmatism</strong>.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">They can be used to <strong>correct corneal astigmatism</strong> of <strong>1D</strong> and above.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/27/picture7_uXCS4uB.jpg\" style=\"height:286px; width:300px\" /></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. TORIC ICL (Implantable Collamer Lens) Implantation&nbsp;</span></strong><span style=\"font-size:12.0pt\">are used to <strong>correct refractive errors</strong>, including <strong>myopia</strong> and <strong>astigmatism</strong>. However, they are not typically used for cataract surgery. ICLs are <strong>implanted</strong> in addition to the <strong>natural lens</strong> and are more commonly used in <strong>refractive surgery</strong> for patients <strong>without cataracts</strong>.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. </span></strong><span style=\"font-size:12.0pt\">While phacoemulsification with the implantation of a multifocal IOL is an <strong>effective treatment</strong> for <strong>cataracts</strong> and can provide a <strong>range of vision</strong> (near to far), multifocal IOLs do not specifically correct astigmatism. They are <strong>more focused</strong> on <strong>reducing</strong> the <strong>need</strong> for <strong>reading glasses</strong> or <strong>bifocals post-surgery</strong>.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. MSICS (Manual Small Incision Cataract Surgery)&nbsp;</span></strong><span style=\"font-size:12.0pt\">is an <strong>effective method</strong> for <strong>cataract removal</strong>, especially in developing countries or in cases where <strong>phacoemulsification equipment</strong> is <strong>not available</strong>. However, this procedure does not inherently correct astigmatism.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The <strong>most appropriate choice</strong> for a patient needing both <strong>cataract surgery</strong> and <strong>astigmatism correction</strong> is <strong>Phacoemulsification with Toric IOLs Implantation</strong>. This option <strong>directly addresses</strong> the <strong>cataract</strong> through <strong>phacoemulsification</strong> and <strong>corrects astigmatism</strong> with the <strong>implantation</strong> of a <strong>toric IOL</strong>.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Ref:&nbsp;</span></u></strong><strong><span style=\"font-size:12.0pt\">Pg 310/ Intraocular Lenses/ Theory &amp; Practise of Optics of Refraction</span></strong></span></span></p>",
      "correct_choice_id": 74127,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 18543,
      "choices": [
        {
          "id": 74130,
          "text": "<p><span style=\"font-size:12.0pt;\">Iris Hooks Insertion.</span></p>"
        },
        {
          "id": 74131,
          "text": "<p><span style=\"font-size:12.0pt;\">Multifocal IOLs Insertion.</span></p>"
        },
        {
          "id": 74132,
          "text": "<p><span style=\"font-size:12.0pt;\">LASIK</span></p>"
        },
        {
          "id": 74133,
          "text": "<p><span style=\"font-size:12.0pt;\">Capsular Tension Rings (CTR) Insertion.</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">A cataract surgeon noticed zonular dehiscence in a patient preoperatively of less than 2 clock hours. What precaution can be taken during surgery?</span></p>",
      "unique_key": "Q6165091",
      "question_audio": null,
      "question_video": null,
      "map_id": 31208,
      "difficulty_level": "intermediate",
      "subjects_id": [
        8
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) Capsular Tension Rings (CTR) Insertion</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D.</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">The presence of <strong>zonular weakness increases</strong> the risk of <strong>intra</strong>- and <strong>postoperative complications</strong> from <strong>cataract surgery</strong>, including <strong>posterior capsular rupture</strong>, <strong>vitreous loss</strong>, and <strong>lens dislocation</strong> and <strong>decentration</strong>.</span></li><li><span style=\"font-size:12.0pt;\">Capsular support devices <strong>facilitate safe</strong> and <strong>successful cataract surgery</strong> by <strong>improving capsular</strong> <strong>bag stability</strong> and <strong>centration</strong>.</span></li><li><span style=\"font-size:12.0pt;\">These devices consist of <strong>capsular tension rings</strong> (A), <strong>modified capsular tension rings</strong> (B), <strong>capsular tension segments</strong> (C), and <strong>capsular retention hooks</strong> (D).&nbsp;</span></li></ul><p style=\"margin-left:48px;text-align:center;\"><br><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/27/screenshot-2024-01-27-130531.jpg\" alt=\"\" width=\"400\" height=\"214\"></p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><u>Explanation:</u></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A.&nbsp;</strong>Iris hooks are used to <strong>mechanically dilate</strong> the <strong>pupil</strong> in cases where <strong>pharmacological dilation</strong> is <strong>insufficient</strong>. While they provide <strong>better visualization</strong> during <strong>surgery</strong>, they do not address zonular dehiscence or the stability of the lens capsule.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B.&nbsp;</strong>Multifocal IOLs provide a <strong>range of</strong> <strong>vision</strong> <strong>post-cataract surgery</strong> but have no role in managing zonular dehiscence. The choice of IOL doesn't directly impact the surgical approach to zonular weakness.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C.&nbsp;</strong>LASIK (Laser-Assisted in Situ Keratomileusis) is a <strong>refractive surgery procedure</strong> for <strong>correcting vision issues</strong> like <strong>myopia</strong>, <strong>hyperopia</strong>, and <strong>astigmatism</strong>. It is unrelated to the management of zonular dehiscence in cataract surgery.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><u>Educational Objective:</u></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Given the scenario of <strong>zonular dehiscence</strong> of <strong>less than 2 clock hours</strong>, the <strong>precaution</strong> that can be taken <strong>during cataract surgery</strong> is <strong>- Capsular Tension Rings (CTR) insertion</strong>. This approach helps to <strong>manage</strong> the <strong>weakened zonular support</strong> <strong>effectively</strong>, ensuring a <strong>safer surgical procedure</strong> and <strong>better outcomes</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><u>Ref:&nbsp;</u>https://eyewiki.aao.org/Capsular_Support_Devices</strong></span></p>",
      "correct_choice_id": 74133,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 18547,
      "choices": [
        {
          "id": 74146,
          "text": "<p><span style=\"font-size:12.0pt;\">Anterior Capsulotomy</span></p>"
        },
        {
          "id": 74147,
          "text": "<p><span style=\"font-size:12.0pt;\">Arcuate Keratotomies</span></p>"
        },
        {
          "id": 74148,
          "text": "<p><span style=\"font-size:12.0pt;\">Nuclear Fragmentation</span></p>"
        },
        {
          "id": 74149,
          "text": "<p><span style=\"font-size:12.0pt;\">All the above</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">In FLACS (Femto Laser Assisted Cataract Surgery), what is the Femto Laser used for?</span></p>",
      "unique_key": "Q4818401",
      "question_audio": null,
      "question_video": null,
      "map_id": 31212,
      "difficulty_level": "beginner",
      "subjects_id": [
        8
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) All the above</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D.</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>Femtosecond laser assisted cataract surgery (FLACS)</strong> is a recent development in the&nbsp;history of cataract surgery.</span></li><li><span style=\"font-size:12.0pt;\">The <strong>femtosecond laser</strong> can be used to <strong>create cleavage planes</strong> via <strong>photo disruption</strong> in <strong>transparent/translucent tissues</strong>.</span></li><li><span style=\"font-size:12.0pt;\">The laser can be used to <strong>assist</strong> the <strong>surgeon</strong> by <strong>creating tissue planes</strong> for:</span><ol style=\"list-style-type:lower-latin;\"><li><span style=\"font-size:12.0pt;\">Wounds</span></li><li><span style=\"font-size:12.0pt;\">Arcuate Keratotomies</span></li><li><span style=\"font-size:12.0pt;\">Anterior Capsulotomies</span></li><li><span style=\"font-size:12.0pt;\">Nuclear Fragmentation</span></li></ol></li></ul><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/27/screenshot-2024-01-27-131110.jpg\" alt=\"\" width=\"350\" height=\"205\"></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><u>Explanation:</u></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A.&nbsp;</strong>Anterior Capsulotomy: The femtosecond laser is used to create a <strong>precise</strong>, <strong>circular incision</strong> in the <strong>anterior capsule</strong> of the <strong>lens</strong>, which is a <strong>critical step</strong> for <strong>accessing</strong> and <strong>removing</strong> the <strong>cataract</strong>. This <strong>laser-assisted capsulotomy</strong> is known for its <strong>precision</strong> and <strong>reproducibility</strong> compared to the <strong>manual technique</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B.&nbsp;</strong>Arcuate Keratotomies: The femtosecond laser can also be used to <strong>perform arcuate keratotomies</strong>, which are <strong>precise incisions</strong> in the <strong>cornea</strong> to <strong>correct pre-existing astigmatism</strong>. This <strong>enhances</strong> the <strong>refractive outcomes</strong> of <strong>cataract surgery</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C.&nbsp;</strong>Nuclear Fragmentation: The femtosecond laser can <strong>pre-fragment</strong> the <strong>cataractous lens (nucleus)</strong> which can <strong>reduce</strong> the <strong>amount</strong> of <strong>ultrasound energy</strong> (<strong>phacoemulsification</strong>) needed to <strong>subsequently break up</strong> and <strong>remove</strong> the <strong>lens material</strong>, <strong>potentially leading</strong> to <strong>less trauma</strong> to the <strong>eye</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><u>Educational Objective:</u></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The femtosecond laser in FLACS is a <strong>versatile tool</strong> that <strong>enhances</strong> the <strong>precision, safety</strong>, and <strong>refractive outcomes</strong> of <strong>cataract surgery</strong> by <strong>assisting</strong> in <strong>multiple key steps</strong> of the <strong>procedure</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><u>Ref:</u></strong></span><span style=\"font-size:11pt;\"><strong> </strong></span><span style=\"font-size:12.0pt;\"><strong>https://eyewiki.aao.org/Femtosecond_Cataract_Surgery</strong></span></p>",
      "correct_choice_id": 74149,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "InstrumentsBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 18551,
      "choices": [
        {
          "id": 74162,
          "text": "<p><span style=\"font-size:12.0pt;\">In the Anterior Chamber</span></p>"
        },
        {
          "id": 74163,
          "text": "<p><span style=\"font-size:12.0pt;\">Attached to Iris.</span></p>"
        },
        {
          "id": 74164,
          "text": "<p><span style=\"font-size:12.0pt;\">Behind the Iris</span></p>"
        },
        {
          "id": 74165,
          "text": "<p><span style=\"font-size:12.0pt;\">None of the above</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">In case of posterior capsular rupture, where are the GLUED IOLs placed?</span></p>",
      "unique_key": "Q4398457",
      "question_audio": null,
      "question_video": null,
      "map_id": 31213,
      "difficulty_level": "intermediate",
      "subjects_id": [
        8
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) Behind the Iris</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C.</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">The glued IOL technique is a relatively new method for <strong>fixing</strong> a <strong>posterior chamber IOL&nbsp;</strong>in an <strong>eye without a capsule</strong>.</span></li><li><span style=\"font-size:12.0pt;\">The glued IOL technique consists of making <strong>two partial-thickness scleral flaps</strong> <strong>exactly 180 degrees apart</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/27/picture8_lildvhF.jpg\" alt=\"\" width=\"400\" height=\"238\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><u>Explanation:</u></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. In the Anterior Chamber</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>IOLs&nbsp;</strong>are placed in <strong>front</strong> of the <strong>iris</strong>. This option is generally considered when there is <strong>inadequate support</strong> in the <strong>posterior chamber</strong>, but it's <strong>less favored</strong> due to <strong>potential complications</strong> like <strong>corneal endothelial damage</strong> and <strong>secondary glaucoma</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/27/picture9_EUAyMW5.jpg\" alt=\"\" width=\"300\" height=\"238\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/27/picture10_Dy4wc9C.jpg\" alt=\"\" width=\"300\" height=\"300\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Attached to Iris-fixated IOLs&nbsp;</strong>are another option where the <strong>lens</strong> is <strong>attached</strong> to the <strong>iris</strong>. This can be done in cases where there is <strong>insufficient capsular support</strong>, but it <strong>requires sufficient</strong> <strong>structural integrity</strong> of the iris and careful consideration of <strong>potential complications</strong>, such as <strong>iris chafing</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/27/picture11_qiVsq17.jpg\" alt=\"\" width=\"300\" height=\"243\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. None of the Above</strong>: This option is <strong>incorrect</strong> given that one of the above choices <strong>accurately</strong> describes the <strong>placement</strong> of <strong>glued IOLs</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><u>Educational Objective</u></strong><u>:</u></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Understand that in cases of <strong>posterior capsular rupture</strong>, <strong>glued intraocular lenses (IOLs)</strong> are typically placed in the <strong>sulcus</strong>, <strong>behind</strong> the <strong>iris</strong>, using a technique that <strong>secures</strong> the <strong>IOL</strong> to the <strong>sclera</strong> with <strong>fibrin glue</strong> for <strong>stable fixation</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><u>Ref:</u></strong></span><span style=\"font-size:11pt;\"><strong>&nbsp; </strong></span><span style=\"font-size:12.0pt;\"><strong>https://www.aao.org/education/current-insight/glued-iol-technique</strong></span></p>",
      "correct_choice_id": 74164,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 18552,
      "choices": [
        {
          "id": 74166,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Multifocal IOLs</span></span></span></p>"
        },
        {
          "id": 74167,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Accommodative IOLs</span></span></span></p>"
        },
        {
          "id": 74168,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Extended Depth of Focus IOL.</span></span></span></p>"
        },
        {
          "id": 74169,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">All of them.</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Which of the following IOLs is used to correct both distant &amp; near vision?</span></span></span></p>",
      "unique_key": "Q5906594",
      "question_audio": null,
      "question_video": null,
      "map_id": 31214,
      "difficulty_level": "intermediate",
      "subjects_id": [
        8
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. D) All of them.</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">IOLs used for correcting <strong>both distant</strong> &amp; <strong>near vision</strong> together include:</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Trifocal iols</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Bifocal IOLs or Multifocal IOLs</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Diffractive iols</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Accommodative IOLs</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Extended Depth of Focus IOL.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref:</span></span></u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&nbsp; Pg 310/ Theory &amp; Practise of Optics &amp; Refraction/ 4<sup>th</sup> Edition/ AK KHURANA</span></span></strong></p>",
      "correct_choice_id": 74169,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "InstrumentsBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 18553,
      "choices": [
        {
          "id": 74170,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Monofocal IOLs</span></span></span></p>"
        },
        {
          "id": 74171,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Accommodative IOLs</span></span></span></p>"
        },
        {
          "id": 74172,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Piggyback IOLs</span></span></span></p>"
        },
        {
          "id": 74173,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Multifocal IOLs</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Identify the type of IOL.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/27/picture12_Mb5Tooe.jpg\" style=\"height:252px; width:300px\" /></span></span></span></p>",
      "unique_key": "Q8904541",
      "question_audio": null,
      "question_video": null,
      "map_id": 31215,
      "difficulty_level": "intermediate",
      "subjects_id": [
        8
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. D) Multifocal IOLs</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Annulus type&nbsp;</span></strong><span style=\"font-size:12.0pt\">of <strong>multifocal IOL</strong>.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The <strong>central portion</strong> of the <strong>optics</strong> contains <strong>distance vision refraction</strong> and <strong>near vision ring outside</strong> it.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A.&nbsp;</span></strong><span style=\"font-size:12.0pt\">A Monofocal Intra-Ocular Lens (IOL) is an <strong>artificial lens</strong> <strong>implanted</strong> in the <strong>eye</strong> that has a <strong>single fixed focus</strong>, typically set for <strong>distance vision</strong>, requiring the <strong>use</strong> of <strong>glasses</strong> for <strong>near tasks</strong>.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B.&nbsp;</span></strong><span style=\"font-size:12.0pt\">Accommodative IOLs are <strong>advanced artificial lenses</strong> designed to <strong>move</strong> or <strong>change shape inside</strong> the <strong>eye</strong>, <strong>mimicking</strong> the <strong>eye&#39;s natural ability</strong> to <strong>change focus</strong> (<strong>accommodation</strong>) between <strong>distant</strong> and <strong>near objects</strong>.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/27/picture13_NPuiGOw.jpg\" style=\"height:147px; width:300px\" /></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C.&nbsp;</span></strong><span style=\"font-size:12.0pt\">Piggyback IOLs involve the <strong>implantation</strong> of a <strong>second intraocular lens</strong> over an <strong>existing IOL</strong>, usually to <strong>correct</strong> <strong>residual refractive errors</strong> such as <strong>residual myopia</strong>, <strong>hyperopia</strong>, or <strong>astigmatism</strong>.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Multifocal IOLs&nbsp;</span></strong><span style=\"font-size:12.0pt\">are <strong>artificial lenses</strong> <strong>implanted</strong> in the <strong>eye</strong> that have <strong>multiple focus zones</strong> <strong>built</strong> into the <strong>lens</strong>, <strong>allowing</strong> for <strong>clear vision</strong> at various <strong>distances</strong>, <strong>reducing</strong> or <strong>eliminating</strong> the <strong>need</strong> for <strong>glasses</strong>.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></span></u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Pg 317/ Theory &amp; Practise of Optics &amp; Refraction/ 4<sup>th</sup> Edition/ AK KHURANA</span></span></strong></p>",
      "correct_choice_id": 74173,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ImageBased",
        "InstrumentsBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 18568,
      "choices": [
        {
          "id": 74230,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Sphincterotomy</span></span></span></p>"
        },
        {
          "id": 74231,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Phacoemulsification</span></span></span></p>"
        },
        {
          "id": 74232,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Iris Hooks</span></span></span></p>"
        },
        {
          "id": 74233,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Trabeculectomy</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A 55-year-old male diagnosed with right eye immature cataract was planned for cataract surgery. But there was poor pupillary dilatation. The technique shown in the image for dilating the pupil is:</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/27/picture14_lCjL6xa.jpg\" style=\"height:182px; width:400px\" /></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>",
      "unique_key": "Q7061084",
      "question_audio": null,
      "question_video": null,
      "map_id": 31205,
      "difficulty_level": "intermediate",
      "subjects_id": [
        8
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. C) Iris Hooks</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Iris Hook Technique&nbsp;</span></strong><span style=\"font-size:12.0pt\">is useful in patients with <strong>small pupils</strong> and <strong>posterior synechiae</strong>. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">For <strong>dilating</strong> the <strong>pupil</strong>.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">By <strong>marking</strong> the <strong>4 incision sites</strong> for the <strong>hooks</strong> in a <strong>diamond configuration</strong>.&nbsp;</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A.&nbsp;</span></strong><span style=\"font-size:12.0pt\">Sphincterotomy is a <strong>surgical procedure</strong> to <strong>cut</strong> the <strong>iris sphincter</strong> to <strong>achieve mechanical mydriasis</strong>.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B.&nbsp;</span></strong><span style=\"font-size:12.0pt\">Phacoemulsification is a <strong>modern cataract surgery technique</strong> in which an <strong>ultrasound device</strong> is used to <strong>emuslsify cataract</strong> <strong>within</strong> the <strong>eye</strong>.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D.&nbsp;</span></strong><span style=\"font-size:12.0pt\">Trabeculectomy is a <strong>surgical procedure</strong> to <strong>treat glaucoma</strong> by creating a <strong>drainage fistula</strong> in the <strong>eye&#39;s sclera</strong> and <strong>trabecular meshwork</strong> to <strong>lower intraocular pressure</strong> by <strong>allowing aqueous humor</strong> to <strong>drain</strong> into the <strong>subconjunctival space</strong> bypassing the <strong>trabecular meshwork</strong>.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Iris hooks&nbsp;</span></strong><span style=\"font-size:12.0pt\">are <strong>small devices</strong> used <strong>during eye surgery</strong> to <strong>mechanically dilate</strong> the <strong>pupil</strong> and provide <strong>better access</strong> and <strong>visibility</strong>, especially in cases where the pupil does not dilate sufficiently on its own.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref:&nbsp;</span></span></u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">https://www.aao.org/education/clinical-video/iris-hook-technique</span></span></strong></p>",
      "correct_choice_id": 74232,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ImageBased",
        "InstrumentsBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 18527,
      "choices": [
        {
          "id": 74066,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">0.1mg Moxifloxacin </span></span></span></p>"
        },
        {
          "id": 74067,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">1mg Vancomycin + 2.25mg Ceftazidime </span></span></span></p>"
        },
        {
          "id": 74068,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">1mg Vancomycin + 0.4mg Gentamycin </span></span></span></p>"
        },
        {
          "id": 74069,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">2.25mg Ceftazidime + 0.4mg Amikacin </span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A 35-year-old male patient presented with severe ocular pain and redness accompanied with dimunition in vision and discharge. After extensive examination, he was diagnosed with endophthalmitis. Which is the preferred combination of intravitreal antibiotics you will prescribe for this patient?</span></span></span></p>",
      "unique_key": "Q2187554",
      "question_audio": null,
      "question_video": null,
      "map_id": 31216,
      "difficulty_level": "intermediate",
      "subjects_id": [
        8
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. B) 1mg Vancomycin + 2.25mg Ceftazidime</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Intravitreal antibiotics&nbsp;</span></strong><span style=\"font-size:12.0pt\">are the treatment of choice for <strong>endophthalmitis</strong>.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Injected after taking a <strong>0.2&ndash;0.3 ml vitreous biopsy</strong> for preparing <strong>smears</strong> and obtaining <strong>cultures</strong>. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A combination of <strong>vancomycin</strong> (1mg) and <strong>ceftazidime</strong> (2.25mg) is the <strong>preferred combination</strong>. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Amikacin&nbsp;</span></strong><span style=\"font-size:12.0pt\">(0.4 mg in 0.1 ml) or <strong>gentamicin</strong> (0.4 mg in 0.1 ml) are used <strong>less frequently</strong> owing to the <strong>risk</strong> of <strong>macular infarction</strong>.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Simultaneous injection&nbsp;</span></strong><span style=\"font-size:12.0pt\">of <strong>dexamethasone</strong> <strong>0.4 mg</strong> in <strong>0.1 ml</strong> is <strong>optional</strong>.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. 0.1mg Moxifloxacin</span></strong><span style=\"font-size:12.0pt\"> is a <strong>broad-spectrum antibiotic</strong>, but it is not commonly used alone as an <strong>intravitreal injection</strong> for the treatment of <strong>endophthalmitis</strong>. <strong>Monotherapy</strong> is generally <strong>less favored</strong> due to the <strong>diverse range</strong> of <strong>potential infective organisms</strong>.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C.&nbsp;</span></strong><span style=\"font-size:12.0pt\">1mg Vancomycin + 0.4mg Gentamycin</span><span style=\"font-size:12.0pt\">: While this <strong>combination</strong> provides <strong>broad coverage</strong> <strong>against</strong> both <strong>gram-positive</strong> and <strong>gram-negative organisms</strong>, the use of <strong>Gentamycin</strong> has <strong>declined</strong> due to its <strong>potential toxicity</strong>, particularly the <strong>risk</strong> of <strong>macular ischaemia</strong>.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D.&nbsp;</span></strong><span style=\"font-size:12.0pt\">2.25mg Ceftazidime + 0.4mg Amikacin</span><span style=\"font-size:12.0pt\">: Ceftazidime covers <strong>gram-negative bacteria</strong>, and <strong>Amikacin</strong> is another <strong>aminoglycoside</strong> like <strong>Gentamycin</strong>. Like Gentamycin, Amikacin has <strong>potential toxicities</strong>. This combination, while <strong>effective</strong>, is generally <strong>less preferred</strong> due to the concerns of <strong>macular ischaemia</strong> associated with <strong>aminoglycosides</strong>.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The most <strong>appropriate</strong> and <strong>preferred combination</strong> for treating <strong>endophthalmitis</strong> is <strong>1mg Vancomycin + 2.25mg Ceftazidime</strong>. This combination is <strong>broadly effective</strong> <strong>against</strong> the range of bacteria typically <strong>implicated</strong> in <strong>endophthalmitis</strong> and is the <strong>standard of care</strong> in <strong>many clinical settings</strong>.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Ref:&nbsp;</span></u></strong><strong><span style=\"font-size:12.0pt\">Parsons Diseases of Eye 22<sup>nd</sup> Edition Page 243</span></strong></span></span></p>",
      "correct_choice_id": 74067,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 18536,
      "choices": [
        {
          "id": 74102,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">1% Azithromycin </span></span></span></p>"
        },
        {
          "id": 74103,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">5% Povidone Iodine </span></span></span></p>"
        },
        {
          "id": 74104,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">0.5% Moxifloxacin </span></span></span></p>"
        },
        {
          "id": 74105,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">5% Vancomycin </span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A patient who underwent an ocular surgery a week back, now complaints of pain, redness, photophobia and decrease in vision. The surgeon suspects post-operative endophthalmitis. Which of the following topical drugs is known to reduce the risk of post-operative endophthalmitis?</span></span></span></p>",
      "unique_key": "Q2496531",
      "question_audio": null,
      "question_video": null,
      "map_id": 31206,
      "difficulty_level": "intermediate",
      "subjects_id": [
        8
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\">Ans. B) 5% Povidone Iodine</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\">Option B:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Topical povidone-iodine solution</span></strong><span style=\"font-size:12.0pt\">, <strong>5</strong>% <strong>exhibits</strong> <strong>broad-spectrum antimicrobial</strong> activity when used to <strong>prepare</strong> the <strong>surgical field</strong> and to <strong>rinse</strong> the <strong>ocular surface</strong>.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">It is the <strong>only drug</strong> that has had a <strong>significant effect</strong> on <strong>prevention</strong> of <strong>postsurgical endophthalmitis</strong>. </span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. 1% Azithromycin&nbsp;</span></strong><span style=\"font-size:12.0pt\">is a <strong>broad-spectrum antibiotic</strong> and can be used <strong>topically</strong> for <strong>bacterial infections</strong> of the eye. However, it is not the primary agent known for <strong>reducing</strong> the <strong>risk</strong> of <strong>post-operative endophthalmitis</strong>.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. 0.5% Moxifloxacin</span></strong><span style=\"font-size:12.0pt\">: <strong>Moxifloxacin&nbsp;</strong>is a <strong>fourth-generation fluoroquinolone antibiotic</strong> used <strong>topically</strong> for <strong>bacterial infections</strong> of the eye. While it is <strong>effective against</strong> a <strong>range</strong> of <strong>bacteria</strong>, its primary use is not specifically for reducing the <strong>risk</strong> of <strong>post-operative endophthalmitis</strong> in the <strong>same preventive capacity</strong> as <strong>povidone iodine</strong>.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. 5% Vancomycin&nbsp;</span></strong><span style=\"font-size:12.0pt\">is an <strong>antibiotic</strong> that can be used to <strong>treat serious bacterial infections</strong>, including <strong>Methicillin-Resistant Staphylococcus aureus (MRSA)</strong>. It&#39;s not typically used as a prophylactic measure against post-operative endophthalmitis in a topical form.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The <strong>most effective</strong> and <strong>commonly</strong> used agent for <strong>reducing</strong> the <strong>risk</strong> of <strong>post-operative endophthalmitis</strong> is <strong>5% Povidone Iodine</strong>. This antiseptic solution is applied <strong>preoperatively</strong> to the <strong>ocular surface</strong> to <strong>minimize</strong> the <strong>presence</strong> of <strong>potential infectious agents</strong>.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Ref:&nbsp;</span></u></strong><strong><span style=\"font-size:12.0pt\">AAO Section: 2 &ndash; 2020 Edition Page 428</span></strong></span></span></p>",
      "correct_choice_id": 74103,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    }
  ]
}